Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
SciRank is an online platform for the biotechnology industry. Its core purpose is to provide user-generated reviews and ratings of CDMOs and CROs, along with aggregated data on supplier capabilities, helping biotech companies choose outsourcing partners for manufacturing, R&D, clinical supply, and related functions. Its categories include biologics, cell therapy, CROs, clinical trial supply, packaging and labeling, small-molecule services, viral vectors, mRNA, oligonucleotides, and more, making it clearly focused on vertical procurement decisions in the life sciences supply chain.
The platform’s main features are supplier search, category browsing, filtering, and review viewing. Filters include regulatory certifications, continent, state, city, and SciRank rating. Scores come from registered and verified SciRank community members; reviewers must be employees of biotech or pharmaceutical companies and have direct experience using the relevant CDMO/CRO. Rating dimensions include team experience, manufacturing/R&D capabilities, analytical and validation capabilities, quality, cost, raw materials, and transparency. These are combined into a 1–10 score and converted into ratings such as A, AA, and AAA; BB indicates below-benchmark performance or insufficient data.
The website does not disclose specific plan pricing or feature differences, but its refund policy indicates a SaaS subscription model, with monthly or annual automatic billing through a payment provider and a 30-day full refund. Access is gated by industry role: full reviews are available only to logged-in biotech/pharma employees, and submitting a review requires verification with a work email address. CDMOs/CROs can claim profiles using a company email address, publicly respond to reviews, and initiate arbitration for comments suspected to be from non-genuine customers.
The main advantages are that reviews emphasize direct user experience and are moderated, while anonymity helps reduce concerns around giving honest feedback. The scoring dimensions also align well with key CDMO/CRO selection issues such as quality, capability, cost, and transparency. The downsides are that the platform states its information is not comprehensive and does not guarantee accuracy, so it cannot replace due diligence. Specific pricing, third-party integrations, API availability, self-hosting options, and security/compliance certifications are not disclosed, leaving gaps for enterprise IT procurement.
SciRank is best suited to biotech startups, pharmaceutical CMC teams, manufacturing outsourcing teams, supplier management teams, and strategic partnership teams that need to evaluate CDMOs/CROs. It is also useful for CDMOs/CROs that want to showcase their capabilities. The source text does not provide information on access from China, so this remains unknown. Payment methods are described only as automatic billing through a payment provider, and support for common Chinese payment methods is unknown. Chinese users may also want to supplement it with local industry associations, trade show resources, supplier networks such as WuXi AppTec, and professional due diligence channels.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on thescirank.com official site.
thescirank.com is an Unknown SaaS provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach thescirank.com directly.